2,500-square-foot 'open lab' will serve as international hub for collaborative research, biotech start-ups
DETROIT, Feb. 16 /PRNewswire-USNewswire/ -- TechTown, the Wayne State University research and technology park, will soon be home to the first stem cell commercialization lab in Michigan. The Wayne County Stem Cell Commercialization Center is the brainchild of Wayne County Executive Robert Ficano, who publicly announced Wayne County's support for the 2,500-square-foot stem cell research facility in his State of the County address last week.
"Wayne State and its University Research Corridor partners, the University of Michigan and Michigan State, are the greatest medical research assets we have in Michigan," Ficano said, "and now we have a chance to share that brainpower with the rest of the world. TechTown's Stem Cell Commercialization Center will be a place where researchers collaboratively accelerate the development of life-saving drugs, and create high-tech companies that bring those treatments to the global marketplace."
According to Randal Charlton, executive director of TechTown, the lab is already in early-stage discussions with stem cell research teams in Sweden, the United Kingdom and Hungary. He explained that the lab will serve as a common resource for core biological research using stem cells, which scientists can transfigure into a replica of any cell in the body. Stem cells are the raw material for drugs that can treat everything from juvenile diabetes to traumatic brain injury.
"We are looking to collaborate with scientists and research universities internationally," Charlton said. "The United States is the largest health care market in the world, and Wayne County is the best place for biotech companies to do business, especially given the access companies now have to this unique innovation and commercialization resource."
According to Charlton, the lab is particularly valuable to small start-up companies, which rarely have the capital to afford the space and high-tech equipment that the Stem Cell Commercialization Center will provide. He added that companies will also have access to TechTown's business growth development programs and services to aid in commercializing their research findings.
Five biotech start-up companies, spun-off from Wayne State University research, are expected to open headquarters at the Lab upon its completion within the next 6 months.
"We are very pleased that Wayne County is continuing to support TechTown's efforts to strengthen the area's economy by investing in the life sciences and the future of Michigan's stem cell research enterprise," Charlton said.
TechTown is an urban community of entrepreneurs, investors, mentors and corporate partners creating an internationally influential village in Detroit. TechTown brings the resources of Wayne State University to high-technology startup companies so as to diversify and strengthen Michigan's economy in high-growth emerging industries. For more information, visit www.techtownwsu.org
Related medicine technology :1
|SOURCE Wayne State University|
Copyright©2009 PR Newswire.
All rights reserved
. Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure2
. Game Commission Announces EHD Confirmed in Fayette County3
. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy4
. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy5
. Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm6
. Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques7
. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity8
. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor9
. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity10
. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership11
. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals